Related Experiment Video
Updated: May 28, 2026
09:44
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
[Treat-to-target from the patient perspective]
1Deutsche Rheuma-Liga, Majakowskiring 11, 13156, Berlin, Deutschland. erika@gromnica-ihle.de
Zeitschrift Fur Rheumatologie
|October 8, 2011
Summary
German healthcare professionals and patient organizations are developing strategies to implement treat-to-target goals for rheumatoid arthritis (RA). The patient
Area of Science:
- Rheumatology and patient-centered care.
- Health services research and implementation science.
Context:
- The international treat-to-target initiative sets remission or low disease activity as goals for rheumatoid arthritis (RA) patients.
- German medical professionals and the Deutsche Rheuma-Liga are adapting these goals for practical application.
- The patient's perspective is a crucial outcome variable, yet a universally accepted patient-reported outcome (PRO) score is lacking.
Purpose:
- To explore the adaptation and practical realization of treat-to-target goals in Germany, emphasizing patient-reported outcomes.
- To highlight the need for a joint decision-making process between patients and doctors regarding treatment goals and strategies.
- To address the current gap in a combined, scientifically accepted PRO score for RA management.
Summary:
- Healthcare providers and patient groups in Germany are discussing how to implement treat-to-target strategies for rheumatoid arthritis (RA).
- Joint decision-making between patients and physicians on remission goals and patient-reported outcomes (PROs) is essential.
- There is a need for a standardized PRO score to prioritize the patient's perspective in RA care.
Impact:
- Facilitates shared decision-making in rheumatoid arthritis (RA) management.
- Promotes the integration of patient-reported outcomes (PROs) into clinical practice.
- Aims to improve RA patient outcomes through evidence-based, patient-centered strategies and adequate rheumatologist staffing.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...